Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
The deal covers about 69,000 claims and would end a decade-long fight over allegations that talc products caused ovarian cancer.
- On Monday, Johnson & Johnson agreed to pay $5.5 billion to settle about 69,000 talc lawsuits in United States federal and state courts, resolving 99.75 percent of outstanding cases.
- Johnson & Johnson stopped selling Baby Powder in the United States in 2020 after the World Health Organization classified talc as "probably carcinogenic to humans" in 2024, following failed bankruptcy attempts to cap liabilities.
- With more than 67,000 cases pending in the federal MDL, Levin Papantonio attorneys secured a $20 million Florida jury verdict for Alberto Casaretto's family in October 2025, demonstrating the litigation's scope.
- Erik Haas, Johnson & Johnson's litigation head, said the agreement lets the company "put this matter behind it," while lawyers representing the plaintiffs welcomed the settlement as resolution to a decade-long court battle.
- This settlement excludes the United Kingdom, where the largest product liability case in the nation's history remains pending before the High Court, alleging Johnson & Johnson knew about asbestos contamination for decades.
260 Articles
260 Articles
Pharmaceutical Johnson & Johnson proposed to pay $5.5 billion to resolve thousands of outstanding cases of a collective litigation that accused her product Baby Powder (baby talc), withdrawn from the market in 2020, of causing ovarian cancer.
Johnson & Johnson reached an agreement of $5.5 billion to resolve virtually all pending lawsuits in the United States related to their talc-based products....
Johnson & Johnson Company (J&J) offered to pay up to $5.5 billion to solve US processes in which the company is accused of baby powder and other talc-based products causing ovarian cancer, writes BBC. Claimants claim that baby powder and other talc-containing products of the company would cause ovarian cancer.
Johnson & Johnson expressed through a statement that the demands and accusations “have no scientific basis”
Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer
Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer. The drugmaker, which has been fighting talc-related lawsuits for more than a decade, said that the settlement is conditioned on at least 95% of remaining claimants participating. A U.S. bankruptcy court judge denied a $9 billion settlement proposed by company subsidiary Red River Talc last year that would have been on…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
